These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Contact allergy to ibuproxam. Molinini R Contact Dermatitis; 1991 Apr; 24(4):302-3. PubMed ID: 1831108 [No Abstract] [Full Text] [Related]
15. Allergic contact dermatitis to topical preparations of bufexamac. Pan Y; Nixon R Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467 [TBL] [Abstract][Full Text] [Related]
16. Contact sensitivity to oxyphenbutazone. Valsecchi R; Serra M; Foiadelli L; Cainelli T Contact Dermatitis; 1981 May; 7(3):157. PubMed ID: 7273732 [No Abstract] [Full Text] [Related]
17. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)]. Schnuch A; Gefeller O; Uter W Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011 [TBL] [Abstract][Full Text] [Related]
18. Bufexamac: a review of its pharmacological properties and therapeutic efficacy in inflammatory dermatoses. Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS Drugs; 1975; 10(5-6):351-6. PubMed ID: 1204506 [No Abstract] [Full Text] [Related]
19. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome]. Proske S; Uter W; Schnuch A; Hartschuh W Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026 [TBL] [Abstract][Full Text] [Related]
20. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer. Kränke B; Szolar-Platzer C; Komericki P; Derhaschnig J; Aberer W Contact Dermatitis; 1997 Apr; 36(4):212-5. PubMed ID: 9165205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]